Bio-Rad Laboratories (NYSE:BIO) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS
Bio-Rad Laboratories (NYSE:BIO – Get Rating) released its quarterly earnings results on Thursday. The medical research company reported $3.34 earnings per share for the quarter, topping the consensus estimate of $3.24 by $0.10, Briefing.com reports. The business had revenue of $676.80 million for the quarter, compared to analysts’ expectations of $689.28 million. Bio-Rad Laboratories had […]